Probe,,,,,,,,,,,,,,,,Control,,,,,,,
Compound name,Alternative names,Molecular formula,SMILES (unique cis trans),Molecular weight  [g/mol],DOI,ChEMBL ID,PubChem CID,CAS,Mode of action,Animal use,Targeted domain,Target,Target Uniprot ID,References PMID,Patents,Compound name,Alternative names,Molecular formula,SMILES (unique cis trans),Molecular weight [g/mol],ChEMBL ID,PubChem CID,CAS
(R)-9s,TP-009,C15H13ClN4O,C[C@H](c1cccc(C#N)c1)N1C=C(C=C(C1=N)C(N)=O)[Cl],300.1,10.6019/CHEMBL4507301,CHEMBL3799292,44470113,1191908-24-3,Antagonist,Yes,,ADRA1D,P25100,PMID: 26954848,,(S)-9s,,C15H13ClN4O,C[C@@H](c1cccc(C#N)c1)N1C=C(C=C(C1=N)C(N)=O)[Cl],300.1,CHEMBL3797887,127046693,1884353-55-2
(R)-ZINC-3573,,C18H21N5,CN(C)[C@@H]1CCN(C1)c1cc(c2ccccc2)nc2ccnn12,307.2,10.6019/CHEMBL4507322,CHEMBL4520293,95882507,2089389-15-9,Agonist,No,TM5 (Asp184),MRGPRX2,Q96LB1,PMID: 28288109,,(S)-ZINC-3573,,C18H21N5,CN(C)[C@H]1CCN(C1)c1cc(c2ccccc2)nc2ccnn12,307.2,CHEMBL4534980,95882508,2095596-11-3
8RK64,,C14H16N8O2S,C1CN(Cc2c1nc(NC([C@H]1CCN(C1)C#N)=O)s2)C(CN=[N+]=[N-])=O,360.11,10.6019/CHEMBL4800724,CHEMBL4802050,162677482,2705841-52-5,Covalent inhibitor,Yes,Active site (covalent binding to Cys90),UCHL1,P09936,PMID: 32886496,,JYQ88,,C14H16N8O2S,C1CN(Cc2c1nc(NC([C@@H]1CCN(C1)C#N)=O)s2)C(CN=[N+]=[N-])=O,360.11,CHEMBL4802053,162677485,2987636-71-3
A-079,A-967079,C12H14FNO,CC\C(C(\C)=C\c1ccc(cc1)F)=N/O,207.25,10.6019/CHEMBL4507256,CHEMBL3697701,60150207,1170613-55-4,Antagonist,Yes,,TRPA1,O75762,"PMID: 22319196, PMID: 21402443",,A-226,A-1115226,C13H16FNO,CC\C(C(\C)=C\c1ccc(c(C)c1)F)=N/O,221.1,CHEMBL3701197,87522699,1170614-31-9
A-1155463,,C35H32FN5O4S2,CN(C)CC#Cc1ccc(c(c1)F)OCCCc1c(C(O)=O)nc(N2CCc3cccc(C(Nc4nc5ccccc5s4)=O)c3C2)s1,669.2,10.6019/CHEMBL4507311,CHEMBL3342332,59447577,1235034-55-5,Inhibitor,Yes,BCL domain (hydrophobic P4 pocket),BCL2L1,Q07817,"PMID: 25313317, PMID: 25787766, PMID: 28946654",,A-1107969,,C34H26N8O4S2,C1CN(Cc2c1cccc2C(Nc1nc2ccccc2s1)=O)c1nc(C(O)=O)c(CCOc2ccc(cc2)n2c3c(cncn3)cn2)s1,674.2,CHEMBL3342191,46836243, 1235033-39-2
A-1211212,Bcl2-IN-1,C47H54ClN7O7S,CC1(C)CCC(CN2CCN(CC2)c2ccc(C(NS(c3ccc(c(c3)[N+]([O-])=O)NC[C@@H]3CC[C@H](CC3)OC)(=O)=O)=O)c(c2)Oc2cc3cc[nH]c3nc2)=C(C1)c1ccc(cc1)[Cl],895.3,10.6019/CHEMBL4507310,CHEMBL4228713,49846946,1257044-75-9,Inhibitor,Yes,,BCL2,P10415,"PMID: 25787766 (Secondary paper), PMID: 29745420 (Secondary paper)",US8563735B2,A-1210227,,C44H41ClF3N7O7S,C1COCCC1CNc1ccc(cc1[N+]([O-])=O)S(NC(c1ccc(cc1Oc1cc2cc[nH]c2nc1)N1CCN(CC1)Cc1ccc(cc1c1ccc(cc1)[Cl])C(F)(F)F)=O)(=O)=O,903.2,CHEMBL4551344,155555047,2772401-02-0
A-1596586,CFTR corrector 4,C29H27F2NO7,COc1ccc2c(c1)O[C@H](C[C@H]2NC(C1(CC1)c1ccc2c(c1)OC(O2)(F)F)=O)c1ccc(c(c1)OC)OC,539.2,10.6019/CHEMBL4507262,CHEMBL4093612,121301295,1918142-34-3,Corrector,No,,CFTR,P13569,PMID: 29251932 (Probe: Cmp.13/ control: Cmp. 12),,A-1596584,,C29H27F2NO7,COc1ccc2c(c1)O[C@@H](C[C@@H]2NC(C1(CC1)c1ccc2c(c1)OC(O2)(F)F)=O)c1ccc(c(c1)OC)OC,539.2,CHEMBL4066040,121301422,1918142-35-4
A-192621,,C33H38N2O6,CCCOc1ccc(cc1)[C@H]1[C@H](C(O)=O)[C@H](CN1CC(Nc1c(CC)cccc1CC)=O)c1ccc2c(c1)OCO2,558.3,10.6019/CHEMBL4507261,CHEMBL332794,5310991,195529-54-5,Antagonist,Yes,,EDNRB,P24530,"PMID: 12193066, PMID: 12193067 ",,A-1806262,,C33H38N2O6,CCCOc1ccc(cc1)[C@@H]1[C@@H](C(O)=O)[C@@H](CN1CC(Nc1c(CC)cccc1CC)=O)c1ccc2c(c1)OCO2,558.3,CHEMBL4533479,101933292,195529-26-1
A-446,,C19H19N7OS,C(C(Nc1nnc(N2C[C@H]3C[C@@H]2CN3c2cccnn2)s1)=O)c1ccccc1,393.14,10.6019/CHEMBL4800721,CHEMBL4802038,162677476,,Inhibitor,Yes,Allosteric site at the dimer‐dimer interface,GLS,O94925,,,A-426,,C19H19N7OS,[H][C@@]12CCN(c3nnc(NC(Cc4ccccc4)=O)s3)[C@]1([H])CN2c1cccnn1,393.14,CHEMBL4802049,162677481,
A-485,,C25H24F4N4O5,C[C@@H](C(F)(F)F)N(Cc1ccc(cc1)F)C(CN1C([C@]2(CCc3cc(ccc23)NC(NC)=O)OC1=O)=O)=O,536.16,10.6019/CHEMBL4507259,CHEMBL4282264,118958122,1889279-16-6,Inhibitor,Yes,HAT-Domain,"EP300, CREBBP","Q09472, Q92793",PMID: 28953875,,A-486,,C25H24F4N4O5,C[C@@H](C(F)(F)F)N(Cc1ccc(cc1)F)C(CN1C([C@]2(CCc3ccc(cc23)NC(NC)=O)OC1=O)=O)=O,536.16,CHEMBL4536197,137332060,2143464-15-5
ABT-100,A-409100,C27H19F3N4O3,Cn1cncc1[C@](COc1ccc(C#N)cc1c1ccc(cc1)OC(F)(F)F)(c1ccc(C#N)cc1)O,504.1,10.6019/CHEMBL4507257,CHEMBL4586794,6451154,450839-40-4,Inhibitor,Yes,Transferase,FNTB,P49356,"PMID: 16222147, DOI: 10.1016/j.tet.2005.02.072",,A-108,A-409108,C27H19F3N4O3,Cn1cncc1[C@@](COc1ccc(C#N)cc1c1ccc(cc1)OC(F)(F)F)(c1ccc(C#N)cc1)O,504.1,CHEMBL4526341,10278851,2772250-53-8
ABT-546,A-216546,C30H48N2O6,CCCCN(CCCC)C(CN1C[C@H](c2cc(c3c(c2)OCO3)OC)[C@@H](C(O)=O)[C@@H]1CC(C)(C)CCC)=O,532.4,10.6019/CHEMBL4507258,CHEMBL111612,9915028,212481-66-8,Antagonist,Yes,,EDNRA,P25101,PMID: 10082200,,A-545,A-216545,C30H48N2O6,CCCCN(CCCC)C(CN1C[C@@H](c2cc(c3c(c2)OCO3)OC)[C@H](C(O)=O)[C@H]1CC(C)(C)CCC)=O,532.4,CHEMBL4513786,91827581,212481-66-8
ABT-724,A-369724,C17H19N5,C1CN(CCN1Cc1nc2ccccc2[nH]1)c1ccccn1,293.2,10.6019/CHEMBL4507260,CHEMBL440687,5025739,587870-77-7,Agonist,Yes,,DRD4,P21917,"PMID: 15087502, PMID: 15239663",,A-769,A-423769,C18H21N5S,CSc1cccnc1N1CCN(CC1)Cc1nc2ccccc2[nH]1,339.15,CHEMBL4533008,155547662,1026610-76-3
BAY 1753011,Pecavaptan,C22H19Cl2F3N6O3,C[C@@H](c1nc(CN2C(N(C[C@@H](C(F)(F)F)O)C(c3ccc(cc3)[Cl])=N2)=O)nn1c1cccc(c1)[Cl])O,542.08,,CHEMBL4594444,121301508,1914998-56-3,Antagonist,Yes,,"AVPR1A, AVPR2","P37288, P30518","PMID:  31274842, PMID: 32946151, PMID: 33188886 (clinical trial)",,BAY-2297,,C21H16Cl2F3N5O2,C(c1cncn1c1cccc(c1)[Cl])N1C(N(C[C@@H](C(F)(F)F)O)C(c2ccc(cc2)[Cl])=N1)=O,497.06,,,
BAY 1816032,,C27H24F2N6O4,COc1cnccc1Nc1c(cnc(c2c3ccccc3n(Cc3c(cc(cc3F)OCCO)F)n2)n1)OC,534.18,10.6019/CHEMBL5058649,CHEMBL5084426,118958833,1891087-61-8,inhibitor,Yes,ATP binding domain,BUB1,O43683,PMID: 30429199,,BAY-283,,C29H27F2N5O4,COc1ccccc1Nc1c(cnc(c2c3ccccc3n(Cc3c(cc(cc3F)OCCCO)F)n2)n1)OC,547.2,CHEMBL5082184,166630510,
BAY-069,,C22H14ClF3N2O3,Cc1ccccc1Oc1cc(c2ccccc2c1[Cl])N1C(C=C(C(F)(F)F)NC1=O)=O,446.06,10.6019/CHEMBL4507325,CHEMBL4551635,155555842,2639638-67-6,Inhibitor,Yes,Substrate site in front of co-factor PLP,"BCAT1, BCAT2","P54687, O15382",PMID: 36261130 (Compound 36 a),WO2021063821A1 (Example 32),BAY-771,,C22H15F3N2O3,Cc1ccccc1Oc1cc(c2ccccc2c1)N1C(C=C(C(F)(F)F)NC1=O)=O,412.10,CHEMBL4572210,155563095,2771756-82-0
BAY-091,Compound 60,C26H21FN4O2,CC[C@H](C(O)=O)Nc1c(C#N)c(c2ccc(cc2)c2cccc(C)c2F)nc2cnccc12,440.16,10.6019/CHEMBL4800729,CHEMBL4802045,155884467,2922280-34-8,Inhibitor,No,Kinase hinge motif (Val 199),PIP4K2A,P48426,PMID: 34699202,,BAY-0361,,C26H21FN4O2,CC[C@@H](C(O)=O)Nc1c(C#N)c(c2ccc(cc2)c2cccc(C)c2F)nc2cnccc12,440.16,CHEMBL4802048,162677480,2922507-64-8
BAY-179,,C23H21N5OS,C1CN(CCC1c1nc(cs1)c1cc2ccccc2o1)Cc1nc2c(cccn2)[nH]1,415.2,10.6019/CHEMBL4507313,CHEMBL4538849,155548816,2764880-87-5,Inhibitor,Yes,"Quinone binding site (MT-ND1, NDUFS2/7)",NDUFS2 (Complex 1),O75306,DOI: 10.1021/acsmedchemlett.1c00666,,BAY-070,,C23H23N7S,Cn1c2ccccc2nc1c1csc(C2CCN(CC2)Cc2nc3c(cccn3)[nH]2)n1,429.2,CHEMBL4545807,155553652,
BAY-1797,,C20H17ClN2O4S,C(C(Nc1ccc(c(c1)S(N)(=O)=O)Oc1cccc(c1)[Cl])=O)c1ccccc1,416.9,10.6019/CHEMBL4507265,CHEMBL4521594,124125214,2055602-83-8,Inhibitor,Yes,,P2RX4 ,Q99571,PMID: 31746599,,BAY-207,,C22H18Cl2N2O4S,C1CC1(C(Nc1ccc(c(c1)S(N)(=O)=O)Oc1cccc(c1)[Cl])=O)c1ccccc1[Cl],477.36,CHEMBL4516843,155540682,2407177-57-3 
BAY-277,,C44H52N8O5,C(CCC(N1CCC(CC1)c1ccc2C(N(Cc2c1)C1CCC(NC1=O)=O)=O)=O)CCN1CCC(CC1)c1ccc(cc1)OC1C2CCCCC=2c2nncn2N=1,772.41,,,,,degrader,Yes,,METAP2,P50579,,,BAY-8805,,C44H54N8O4,C(CCC(N1CCC(CC1)c1ccc2C(N(Cc2c1)C1CCCNC1=O)=O)=O)CCN1CCC(CC1)c1ccc(cc1)OC1C2CCCCC=2c2nncn2N=1,758.43,,,
BAY-293,,C25H28N4O2S,Cc1nc(c2cc(c(cc2n1)OC)OC)N[C@H](C)c1cc(cs1)c1ccccc1CNC,448.58,10.6019/CHEMBL4507273,CHEMBL4535474,137322663,2244904-70-7,Inhibitor,No,RAS GEF,SOS1,Q07889,PMID: 30683722,,BAY-294,,C25H28N4O2S,Cc1nc(c2cc(c(cc2n1)OC)OC)N[C@@H](C)c1cc(cs1)c1ccccc1CNC,448.58,CHEMBL4520788,138973681,2244904-69-4
BAY-3153,,C25H29Cl2N3O4,CCOc1cc(ccc1[Cl])N1C2CN(CC1COC2)C([C@H]1C[C@@H](CN1c1ccc(cc1)[Cl])O)=O,505.2,10.6019/CHEMBL4630906,CHEMBL4638406,156011311,2771319-69-6,Antagonist,Yes,,CCR1,P32246,,,BAY-173,,C24H27Cl2N3O3,C1[C@@H](CN(c2ccc(cc2)[Cl])[C@H]1C(N1CC2COCC(C1)N2Cc1ccc(cc1)[Cl])=O)O,475.1,CHEMBL4647642,156021282,
BAY-3827,,C27H25FN6O,CCc1ccccc1C(Nc1c2cc(C3C(C#N)=C(C)N(C)C(C)=C3C#N)c(c(C)c2[nH]n1)F)=O,468.5,10.6019/CHEMBL4507319,CHEMBL4580220,134817183,2377576-35-5,Inhibitor,No,ATP-binding domain of PRKAA1,"PRKAA1, RPS6KA1","Q13131, Q15418","PMID: 33492659, DOI: 10.1158/1538-7445.AM2018-5873 ",,BAY-974,,C25H22N6O,CC1=C(C#N)C(C(C#N)=C(C)N1)c1ccc2c(c1)c(NC(c1ccccc1C)=O)nn2C,422.19,CHEMBL4591350,155568465,2772719-67-0
BAY-386,,C22H25F3N4O5S,C1CC1c1nc([C@H]2C[C@H](CN(C2)C(N2CCS(CC2)(=O)=O)=O)c2ccc(cc2)OC(F)(F)F)on1,514.15,10.6019/CHEMBL4507269,CHEMBL4529330,154701640,1256941-06-6,Antagonist,Yes,,F2R,P25116,,WO2010136138A1 (Example 10/11),BAY-448,,C19H21F3N4O4S,Cc1nc([C@H]2C[C@H](CN(C2)C(N2CCS(C2)(=O)=O)=O)c2ccc(cc2)C(F)(F)F)on1,458.12,CHEMBL4574457,155564507,2772376-09-5
BAY-390,,C13H15F4NO,C1CC[C@@]([C@@H](C1)Nc1ccc(cc1)F)(C(F)(F)F)O,277.11,10.6019/CHEMBL4507328,CHEMBL4514203,155539293,2741956-55-6,Inhibitor,Yes,,TRPA1,O75762,PMID: 36622903,WO2021233752 (Example 16),BAY-9897,,C14H17F4NO2,COc1cc(ccc1F)N[C@@H]1CCCC[C@@]1(C(F)(F)F)O,307.12,CHEMBL4555711,155556859,2883405-51-2
BAY-474,,C17H15N5,CC1=C(C#N)C(C(C#N)=C(C)N1)c1ccc2c(c1)c(C)n[nH]2,289.1,10.6019/CHEMBL4507263,CHEMBL4593677,24959105,1033767-86-0,Inhibitor,Yes,Kinase domain,MET,P08581,,,BAY-827,,C22H16ClN5,CC1=C(C#N)[C@H](C(C#N)=C(c2ccc(cc2)[Cl])N1)c1ccc2c(c1)c(C)n[nH]2,385.9,CHEMBL4522773,155543618,2772447-46-6
BAY-549,"TC-S 7001, Azaindole-1, ROCK-IN-2",C18H13ClF2N6O,Cc1c[nH]c2c1c(ccn2)Oc1c(cc(cc1F)Nc1cc(nc(N)n1)[Cl])F,403,10.6019/CHEMBL4507274,CHEMBL1971943,11524200,867017-68-3,Inhibitor,Yes,kinase catalytic domain,"ROCK1, ROCK2","Q13464, O75116",PMID: 18973168 (Compound 32),,BAY-4900,,C18H12Cl2F2N6O,Cn1cc(c2c(ccnc12)Oc1c(cc(cc1F)Nc1cc(nc(N)n1)[Cl])F)[Cl],436,CHEMBL4546802,155552454,2772751-40-1
BAY-6096,,C21H23N6O2.Cl,Cc1c(c2cnc3cc(ccn23)C(NCC[n+]2ccc(cc2)NC)=O)c(C)on1.[Cl-],426.16,,,153534231,,Antagonist,Yes,"GLN-168, ASP-92 and PHE-388 are directly interacting with the ligand",ADRA2B,P18089,PMID: 36932954 (Compound 24),,BAY-726,,C23H27N6O2.C H O2,Cc1c(c2cnc3cc(ccn23)C(NCCC[n+]2ccc(cc2)N(C)C)=O)c(C)on1.C([O-])=O,464.22,,,
BAY-6672,,C26H27BrClN3O3,Cc1c(C(NC[C@H](CCC(O)=O)c2ccccc2[Cl])=O)c2cc(ccc2nc1N1CCCC1)[Br],543.09,10.6019/CHEMBL4630901,CHEMBL4643852,146368333,2247517-53-7,Antagonist,Yes,,PTGFR,P43088,PMID: 32969660,,BAY-403,,C26H28BrClN4O3,Cc1c(C(NC[C@H](CCC(O)=O)c2ccccc2[Cl])=O)c2cc(ccc2nc1N1CCNCC1)[Br],558.1,CHEMBL4642079,156016206,2772921-54-5
BAY-678,,C20H15F3N4O2 ,CC1=C(C(C)=O)[C@@H](c2ccc(C#N)nc2)NC(N1c1cccc(c1)C(F)(F)F)=O,400.35,10.6019/CHEMBL4507272,CHEMBL3617968,23728722,675103-36-3,Inhibitor,Yes,S1 and S2 pockets,ELANE,P08246,PMID: 26083237 (Compound 20),,BAY-677,,C20H15F3N4O2    ,CC1=C(C(C)=O)[C@H](c2ccc(C#N)nc2)NC(N1c1cccc(c1)C(F)(F)F)=O,400.35,CHEMBL4520674,68944900,2117404-84-7
BAY-707,,C15H20N4O2,CCNC(c1cc2c(ccnc2[nH]1)N1CCOC[C@@H]1C)=O,288.34,10.6019/CHEMBL4507271,CHEMBL4552345,129012086,2109805-96-9,Inhibitor,Yes,Active site,NUDT1,P36639,"PMID:  28679043, PMID: 29485874",,BAY-604,,C16H22N4O2,CCNC(c1cc2c(ccnc2n1C)N1CCOC[C@@H]1C)=O,302.17,CHEMBL4560038,155510461,2223016-60-0
BAY-7081,,C19H26N4O,CCC[C@H]1CNCC2=C1NC(C(C#N)=C2N1CCC2(CC1)CC2)=O,326.21,,,,,Inhibitor,Yes,lipophilic pocket,PDE9A,O76083,PMID: 36475653,,BAY-7424,,C19H26N4O,CCC[C@@H]1CNCC2=C1NC(C(C#N)=C2N1CCC2(CC1)CC2)=O,326.21,,,
BAY-7598,,C28H31N3O6,C1COCCC1CCOc1ccc(cc1)C([C@H]1CC[C@@H](CN2C(c3ccccc3N=N2)=O)[C@@H]1C(O)=O)=O,506,10.6019/CHEMBL4507264,CHEMBL4585243,118425786,1816257-74-5,Inhibitor,Yes,Metallopeptidase domain,MMP12,P39900,,WO2015150350A1 (Probe/control: Example 5/6),BAY-694,,C28H31N3O6,C1COCCC1CCOc1ccc(cc1)C([C@@H]1CC[C@H](CN2C(c3ccccc3N=N2)=O)[C@H]1C(O)=O)=O,506,CHEMBL4539943,155549686,1816257-75-6
BAY-784,BAY 1214784,C29H26ClF4N3O5S2,C1CC1[C@H]1C2(CCS(CC2)(=O)=O)c2cc(ccc2N1S(c1ccc(cc1)F)(=O)=O)C(NCc1c(cc(cn1)C(F)(F)F)[Cl])=O,672.11,10.6019/CHEMBL4507266,CHEMBL4537788,85469632,1631164-24-3,Antagonist,Yes,,GNRHR,P30968,PMID: 32960053 (Compound 5a/ BAY 1214784) ,,BAY-786,,C29H26ClF4N3O5S2,C1CC1[C@@H]1C2(CCS(CC2)(=O)=O)c2cc(ccc2N1S(c1ccc(cc1)F)(=O)=O)C(NCc1c(cc(cn1)C(F)(F)F)[Cl])=O,672.11,CHEMBL4564312,118877194,1631164-25-4
BAY-826,,C26H19F5N6OS,Cc1cc(C)c(cc1NC(c1cc(C#N)cc(c1)S(F)(F)(F)(F)F)=O)n1ccn2c1cc(c1cccnc1)n2,559,10.6019/CHEMBL4507270,CHEMBL3907057,71623052,1448316-08-2,Inhibitor,Yes,Kinase domain,"TIE1, TEK tyrosine kinase, endothelial, DDR1, DDR2","P35590, Q02763, Q08345, Q16832",PMID: 27787897,,BAY-309,,C24H18F5N5OS,Cc1cc(cc(c1)n1ccn2c1cc(c1cccnc1)n2)NC(c1cccc(c1)S(F)(F)(F)(F)F)=O,519.1,CHEMBL4526351,155544007,2772526-21-1
BAY-876,,C24H16F4N6O2               ,Cc1c(c(C(F)(F)F)nn1Cc1ccc(C#N)cc1)NC(c1cc(C(N)=O)nc2cc(ccc12)F)=O,496.1,10.6019/CHEMBL4507267,CHEMBL4448899,118191391,1799753-84-6,Inhibitor,Yes,,SLC2A1,P11166,"PMID: 27552707, PMID: 30861255 (Secondary paper), PMID: 30602670 (Secondary paper)",,BAY-588,,C27H25F4N5O2               ,Cc1c(c(C(F)(F)F)nn1Cc1ccc(cc1)C(C)(C)C)NC(c1cc(C(N)=O)nc2cc(ccc12)F)=O,527.51,CHEMBL4552180,124203924,1799759-24-2
BAY-885,,C25H28F3N7O2,CN1CCN(CC1)c1cc2c(c(C3CCN(CC3)C(c3ccc(cc3N)OC(F)(F)F)=O)ncn2)nc1,515.2,10.6019/CHEMBL4507268,CHEMBL4445670,134128280,2307249-33-6,Inhibitor,No,Kinase domain,MAPK7,Q13164,PMID: 30563338,,BAY-693,,C26H30F3N7O2,Cc1nc(C2CCN(CC2)C(c2ccc(cc2N)OC(F)(F)F)=O)c2c(cc(cn2)N2CCN(C)CC2)n1,529.5,CHEMBL4455582,154701643,2306302-48-5
BAY-899,,C25H19F2N5O2,C1CN(C(Nc2cnc(nc2)Oc2ccc(cc2)F)=O)[C@@H](c2ccc(cc2)F)c2cccnc12,459.2,10.6019/CHEMBL4507317,CHEMBL4458424,139600336,2471967-92-5,Allosteric antagonist,Yes,remnants of the rhodopsin binding site,LHCGR,P22888,PMID: 31670515,,BAY-897,,C27H21F2N3O2,C1CN(C(Nc2ccc(cc2)Oc2ccc(cc2)F)=O)[C@H](c2ccc(cc2)F)c2cccnc12,457.2,CHEMBL4592872,155568985,2471966-91-1
BAY-985,,C27H30F3N9O,C[C@H](c1ccnc(c1)Nc1nc2ccc(cc2[nH]1)c1cc(ncn1)N(C)C)N1CCN(CC1)C(CC(F)(F)F)=O,553.3,10.6019/CHEMBL4507318,CHEMBL4537673,145925685,2409479-29-2,Inhibitor,Yes,Kinase domain (ATP site),"TBK1, IKBKE","Q9UHD2, Q14164",PMID: 31859507,,BAY-440,,C26H27ClF3N9O,CN(C)c1c(c(c2ccc3c(c2)[nH]c(Nc2cc(CN4CCN(CC4)C(CC(F)(F)F)=O)ccn2)n3)ncn1)[Cl],573.2,CHEMBL4538591,137479135,2101927-97-1
BAY1125976,,C23H21N5O,C1CC(C1)(c1ccc(cc1)c1c(c2ccccc2)n2c(ccc(C(N)=O)n2)n1)N,383.17,10.6019/CHEMBL4879553,CHEMBL3545049,70817911,1402608-02-9,Allosteric inhibitor,Yes,Allosteric binding pocket formed by kinase and PH domain,"AKT1, AKT2, AKT3","P31749, P31751, Q9Y243","PMID: 27699769, PMID: 31835495 (Secondary paper)","WO2012136776A1 (Example 5, Control: Example 5)",BAY-940,,C22H20N4O,C1CC(C1)(c1ccc(cc1)c1c(c2ccccc2)n2c(c(ccn2)O)n1)N,356.16,CHEMBL5016886,70818123,1402608-29-0
BI 207127,Deleobuvir,C34H33BrN6O3,Cn1c(c(C2CCCC2)c2ccc(cc12)C(NC1(CCC1)c1nc2ccc(/C=C/C(O)=O)cc2n1C)=O)c1ncc(cn1)[Br],652.2,10.6019/CHEMBL4630904,CHEMBL2403318,56948249,863884-77-9,Inhibitor,Yes,pocket 1 of the thumb domain,HCV NS5B,Q8JXY1,"PMID: 24159919, PMID: 28030579 (Secondary paper), PMID: 27140229 (Secondary paper), PMID: 23856779 (Secondary paper)",WO 2005/080388 A1,BI-7656,,C28H33N5O3,Cn1c2cc(/C=C/C(O)=O)ccc2nc1C1(CCC1)NC(c1ccc(NCC2CCCCC2)nc1)=O,487.3,CHEMBL4637129,156012545,2773352-15-9
BI 605906,,C17H22F2N4O3S2,CCC(c1cc(nc2c1c(c(C(N)=O)s2)N)N1CCC(CC1)S(C)(=O)=O)(F)F,432.11,10.6019/CHEMBL4800722,CHEMBL4522930,23652660,960293-88-3,Inhibitor,Yes,,IKBKB,O14920,"PMID: 21138416, DOI: 10.1021/op900137j (Compound 1)",,BI-5026,,C17H21F3N4O3S2,CN(C)C(c1c(c2c(cc(nc2s1)N1CCC(CC1)S(C)(=O)=O)C(F)(F)F)N)=O,450.1,CHEMBL4802037,162677475,2785323-67-1
BI 639667,"CCR1 antagonist 8, Compound 19n, BI-9667",C22H18FN5O3S,CS(c1cc(ccn1)C1(CC1)NC(c1cncc2c1cnn2c1ccc(cc1)F)=O)(=O)=O,451.5,10.6019/CHEMBL4507278,CHEMBL4456123,52916803,1295298-26-8,Antagonist,Yes,,CCR1,P32246,"PMID: 30595446 (Compound 19n), PMID: 32520562",WO2011049917A1 (Table 1: 6th entry),BI-9307,,C23H23FN6O5S2,CS(c1cc(ccn1)[C@H](CCNS(C)(=O)=O)NC(c1cncc2c1cnn2c1ccc(cc1)F)=O)(=O)=O,547.5,CHEMBL4539555,155550101,2771388-63-5
BI 653048,,C23H25F4N3O4S,CCS(c1cc2cc(C[C@](CC(C)(C)c3ccc(cc3C(N)=O)F)(C(F)(F)F)O)[nH]c2cn1)(=O)=O,515.5,10.6019/CHEMBL4507277,CHEMBL3358954,44543970,1198784-72-3,Agonist,Yes,Ligand binding domain (meta channel),NR3C1,P04150,"PMID: 25516791 (Compound (R)-39), PMID: 28923543 (Sec. paper), PMID: 30908082 (Sec. paper), PMID: 23544738 (Synthesis)",,BI-3047,,C23H25F4N3O4S,CCS(c1cc2cc(C[C@@](CC(C)(C)c3ccc(cc3C(N)=O)F)(C(F)(F)F)O)[nH]c2cn1)(=O)=O,515.5,CHEMBL4531220,58026161,2771580-89-1
BI 665915,,C24H26N8O2,C[C@@](C1CC1)(c1ccc(cc1)c1cnc(N)nc1)c1nc(c2cnn(CC(N(C)C)=O)c2)on1,458.2,10.6019/CHEMBL4507276,CHEMBL3417525,66765019,1360550-05-5,Inhibitor,Yes,membrane domain,ALOX5AP,P20292,PMID: 25671290,"WO 2012024150 A1, US 20130195879",BI-0153,,C22H22N8O2,CN(C)C(Cn1cc(cn1)c1nc(C2(CC2)c2ccc(cc2)c2cnc(N)nc2)no1)=O,430.2,CHEMBL4560241,56849304,1361188-97-7
BI 99179,,C23H25N3O3,CCC(N[C@H]1CC[C@H](C1)C(N(C)c1ccc(cc1)c1nc2ccccc2o1)=O)=O,391.2,10.6019/CHEMBL4507280,CHEMBL1834184,51346964,1291779-76-4,Inhibitor,No,Ketoacyl Reductase (KR) domain,FASN,P49327,PMID: 21873051,,BI 99990,,C23H25N3O3,CCC(N[C@@H]1CC[C@@H](C1)C(N(C)c1ccc(cc1)c1nc2ccccc2o1)=O)=O,391.2,CHEMBL1834199,56678756,1338468-86-2
BI-1230,,C42H52N6O9S,CC(C)C(Nc1nc(cs1)c1cc(c2ccc(c(C)c2n1)OC)O[C@@H]1C[C@H]2C(N[C@@]3(CC3/C=C\CCCCC[C@@H](C(N2C1)=O)NC(=O)OC1CCCC1)C(O)=O)=O)=O,817,10.6019/CHEMBL4507284,CHEMBL4588900,11491332,849022-32-8,Inhibitor,Yes,Protease & RNA helicase domain,HCV NS3,Q91RS4,PMID: 12671967 (Related compounds),WO 2005/028501A1,BI-1675,,C29H38N4O7,C1CC\C=C/C2C[C@@]2(C(O)=O)NC([C@@H]2C[C@H](CN2C([C@H](CC1)NC(=O)OC1CCCC1)=O)Oc1ccncc1)=O,554.6,CHEMBL4516471,155540255,
BI-1935,,C24H21F3N6O3,CCOCCN1C=C(C=CC1=O)C(Nc1ccc(cn1)n1c(cc(c2cccnc2)n1)C(F)(F)F)=O,498.2,10.6019/CHEMBL4507283,CHEMBL4516982,57861407,940954-41-6,Inhibitor,Yes,catalytic domain,EPHX2,P34913,PMID: 20934334 (Related compounds),WO2007067836A2 (Example 3),BI-2049,,C27H17F4N5O,c1ccc(cc1)c1ccc(cc1F)C(Nc1ccc(cn1)n1c(cc(c2cccnc2)n1)C(F)(F)F)=O,503.5,CHEMBL4544690,57861719, 940954-17-6
BI-1942,,C24H26N4O4,CC[C@H](CC(O)=O)N1C(c2c(cccn2)N(Cc2cn(C)c3cc(C)cc(C)c23)C1=O)=O,434.2,10.6019/CHEMBL4800723,CHEMBL3640116,46853762,1236524-95-0,Inhibitor,No,S1 hydrophobic pocket,CMA1,P23946,,WO2010088195A1 (pdf page 11 last row of table),No control,,,,,,,
BI-1950,,C32H26Cl2FN7O3,C[C@@H](C(NC1(CC1)c1ccccn1)=O)NC(c1cnc2N(C([C@@](C)(Cc3ccc(C#N)cc3)n12)=O)c1cc(c(c(c1)[Cl])F)[Cl])=O,646.5,10.6019/CHEMBL4507282,CHEMBL4530740,58431184,1159724-42-1,Inhibitor,Yes,I-domain,ITGAL,P20701,PMID: 30466143,WO2009070485A1 (Compound 56),BI-9446,,C30H25Cl2N7O3,C[C@@]1(Cc2ccc(C#N)cc2)C(N(c2cc(cc(c2)[Cl])[Cl])c2ncc(C(NC3(CC3)c3nc(C4CCC4)no3)=O)n12)=O,602.5,CHEMBL4577237,155554081,2772959-48-3
BI-2081,,C32H35FO6,Cc1cc(cc(C)c1c1ccc(c2c1CC[C@H]2Oc1ccc2c(c1)OC[C@H]2CC(O)=O)F)OCCC(C)(C)O,534.24,10.6019/CHEMBL5058643,CHEMBL5075693,71738995,1458656-71-7,Agonist,Yes,,FFAR1,O14842,,,BI-0340,,C31H33FO7S,Cc1cc(cc(C)c1c1ccc(c2c1CC[C@H]2Oc1ccc2c(c1)OC[C@H]2CC(O)=O)F)S(CCCOC)(=O)=O,568.19,CHEMBL5092999,89809012,1458657-20-9
BI-2540,,C24H15ClF5NO5,Cc1c(ccc(C(O)=O)c1F)NC(COc1ccc(cc1C(c1cc(cc(c1)F)C(F)(F)F)=O)[Cl])=O,527.1,10.6019/CHEMBL4630903,CHEMBL4636332,11706381,875145-22-5,Inhibitor,Yes,allosteric site adjacent to the polymerase active site,HIV NNRT,P03366,DOI: 10.1021/op200301h (Synthesis),US20060025480A1 (Example 11 Compound 1002),BI-2439,,C27H22ClNO5,CC(C)(C#Cc1ccc(c(c1)[Cl])NC(COc1ccccc1C(c1ccccc1)=O)=O)C(O)=O,475.1,CHEMBL4641539,156016701,2773117-43-2
BI-2545,,C23H19F6N5O3,[H][C@]12CN(C[C@]2([H])[C@H]1CNC(c1ccc2c(c1)[nH]nn2)=O)C(=O)OCc1cc(cc(c1)C(F)(F)F)C(F)(F)F,527.4,10.6019/CHEMBL4507275,CHEMBL4165749,131953432,2162961-71-7,Inhibitor,Yes,"Catalytic domain: Zn-binding site, hydrophobic pocket",ENPP2,Q13822,PMID: 29259743 ,,BI-3017,,C20H21N7O3,[H][C@]12CN(C[C@]2([H])[C@H]1CNC(c1ccc2c(c1)nn[nH]2)=O)C(=O)OCc1ccnc(C)n1,407.4,CHEMBL4552354,155554839,2772161-32-5
BI-3231,,C16H14F2N4O3S,CCN1C(C(C)=CN(Cc2nnc(c3ccc(c(c3F)O)F)s2)C1=O)=O,380.08,,,167312378,2894848-07-6,Inhibitor,Yes,"Ser172, Tyr185 (catalytical triad)",HSD17B13,Q7Z5P4,PMID: 36727857 (Compound 45),,BI-0955,,C17H16F2N4O3S,CCN1C(C(C)=CN(Cc2nnc(c3ccc(c(c3F)OC)F)s2)C1=O)=O,394.09,,,2894848-11-2
BI-3802,,C24H29ClN6O3,C[C@H]1C[C@@H](C)CN(C1)c1ncc(c(Nc2ccc3c(C=C(C(N3C)=O)OCC(NC)=O)c2)n1)[Cl],484.2,,CHEMBL4640049,131632978,2166387-65-9,Degrader,No,"BTB/POZ, binds at interface of 2 monomers",BCL6,P41182,"PMID: 28930682, PMID: 33208943",,BI-5273,,C25H30ClN5O4,C[C@H]1C[C@@H](C)CN(C1)c1ncc(c(Nc2ccc3c(C=C(C(N3C)=O)OC(C)(C)C(O)=O)c2)n1)[Cl],499.2,,,
BI-3812,,C26H32ClN7O5,CNC(COC1=Cc2cc(cc(c2N(C)C1=O)OC)Nc1c(cnc(n1)N1CCC(CC1)C(N(C)C)=O)[Cl])=O,557.22,,CHEMBL4755229,134691741,2166387-64-8,Inhibitor,No,"BTB/POZ, binds at interface of 2 monomers",BCL6,P41182,PMID: 28930682,,BI-5273,,C25H30ClN5O4,C[C@H]1C[C@@H](C)CN(C1)c1ncc(c(Nc2ccc3c(C=C(C(N3C)=O)OC(C)(C)C(O)=O)c2)n1)[Cl],499.2,,,
BI-4394,MMP13-IN-3,C24H22N4O5,CCOC(c1cc2cc(ccc2[nH]1)c1cc(C(NCc2ccc(cc2)C(O)=O)=O)nn1C)=O,446.5,10.6019/CHEMBL4507281,CHEMBL1939876,45376872,1222173-37-6,Inhibitor,Yes,S1' pocket (S1'* side pocket),MMP13,P45452,PMID: 22017539 (Compound 15),WO2010045188A1 (Example 5),BI-4395,,C21H18N4O3,Cn1c(cc(C(NCc2ccc(cc2)C(O)=O)=O)n1)c1ccc2c(cc[nH]2)c1,374.4,CHEMBL1939880,56850410,1222173-84-3
BI-8668,,C23H32ClN8O2.Cl,CCn1c2cc(ccc2[n+](CC)c1CNC(c1c(N)ncc(n1)[Cl])=O)C(N(C)CCN(C)C)=O.[Cl-],522.20,,,163183769,2084059-97-0,Inhibitor,Yes,,"SCNN1A, SCNN1B, SCNN1G","P37088, P51168, P51170",,,BI-0337,,C23H33N8O2.Cl,CCn1c2cc(ccc2[n+](CC)c1CNC(c1c(N)nc(C)cn1)=O)C(N(C)CN(C)C)=O.[Cl-],488.24,,163198814,
BI-9627,,C16H19F3N4O2,CC(N1CCC(CC1)c1ccc(cc1C(F)(F)F)C(NC(N)=N)=O)=O,356.3,10.6019/CHEMBL4507279,CHEMBL2170610,51031001,1204329-34-9,Antagonist,Yes,,SLC9A1,P19634,PMID: 22803959 (Compound 60),WO2010005783A1 (Example 91),BI-0054,,C18H21F3N4O2,CC(N1CCC(CC1)c1ccc(cc1C(F)(F)F)C(NC1NCCN=1)=O)=O,382.4,CHEMBL4540759,155550034,
BIBO3304,,C29H35N7O3,C(C[C@H](C(NCc1ccc(CNC(N)=O)cc1)=O)NC(C(c1ccccc1)c1ccccc1)=O)CNC(N)=N,529.28,,CHEMBL1774204,5311022,,Antagonist,Yes,,NPY1R,P25929,PMID: 9806339,,BIBO3457,,C29H35N7O3,C(C[C@@H](C(NCc1ccc(CNC(N)=O)cc1)=O)NC(C(c1ccccc1)c1ccccc1)=O)CNC(N)=N,529.28,,6324607,
BTZO-1,TP-010,C13H8N2OS,c1ccc2c(c1)C(N=C(c1ccccn1)S2)=O,240,10.6019/CHEMBL4507329,CHEMBL4516611,9837640,99420-15-2,ARE Activator,No,Tautomerase,MIF,P14174,PMID: 21168764,,BTZO-4,,C13H10N2OS,c1ccc2c(c1)C(NC(c1ccccn1)S2)=O,242.1,CHEMBL4561806,155558842,1334247-75-4
Borussertib,,C36H32N6O3,C=CC(Nc1ccc2c(c1)N(C1CCN(CC1)Cc1ccc(cc1)c1c(cc3C(NC=Cc3n1)=O) c1ccccc1)C(N2)=O)=O,596.25,10.6019/CHEMBL4800730,CHEMBL4795065,122668091,1800070-77-2,Covalent-allosteric inhibitor ,Yes,Region between kinase and PH-domain (Covalent bond with Cys296),"AKT1, AKT2, AKT3","P31749, P31751, Q9Y243","PMID: 30996949, PMID: 30858154, PMID: 34489430 (Sec. paper)",,RL2578,,C30H29N5O4,C=CC(Nc1ccc2c(c1)N(C1CCN(CC1)Cc1ccc(cc1)c1ccc3c(c1)NC(CO3)=O) C(N2)=O)=O,523.22,CHEMBL4802051,162677483,
CCT369260,,C24H31ClF2N6O2,C[C@@H]1CN(c2nc(Nc3cc(N(C(N4C)=O)CCC(C)(O)C)c4cc3)c(Cl)cn2)C[C@@H](C1(F)F)C,508.22,10.6019/CHEMBL5058646,CHEMBL4445645,135386938,2647503-57-7,Degrader,Yes,BTB domain,BCL6,P41182,PMID: 32275432 (Compound 1),,CCT393732,,C24H32F2N6O2,C[C@@H]1CN(c2nc(Nc3cc(N(C(N4C)=O)CCC(C)(O)C)c4cc3)ccn2)C[C@@H](C1(F)F)C,474.26,CHEMBL5090218,166631442,
CRTH2 antagonist,"CRTH2 antagonist, MK-7246",C21H21FN2O4S,CN([C@@H]1CCc2c(CC(O)=O)c3ccccc3n2C1)S(c1ccc(cc1)F)(=O)=O,416.1,10.6019/CHEMBL4507290,CHEMBL561132,45268455,1218918-62-7,Antagonist,Yes,,PTGDR2,Q9Y5Y4,PMID: 21106375 (MK-7246),,CRTH<sub>2</sub> negative control,CRTH2 negative control,C22H23FN2O6S2,CN([C@@H]1CCc2c(CC(O)=O)c3cc(ccc3n2C1)S(C)(=O)=O)S(c1ccc(cc1)F)(=O)=O,494.1,CHEMBL1643772,53326879,1268339-69-0
ERKi,,C16H17N5O2,C[C@H](c1ccccc1)NC(Nc1cc2c(cn[nH]2)c(CO)n1)=O,311.1,10.6019/CHEMBL4507286,CHEMBL4538174,145925680,2743576-55-6,Inhibitor,Yes,Kinase domain,"MAPK1, MAPK3","P28482, P27361",,,ERKi-NC,,C15H16N6O2,C[C@@H](c1ccccn1)NC(Nc1cc2c(cn[nH]2)c(CO)n1)=O,312.1,CHEMBL4557026,155557179,2772745-24-9
FHT-2344,,C23H24N6O5S2,Cn1ccc(c2cccc(c2)c2csc(NC([C@H](COC)NC(c3ccn(c3)S(C)(=O)=O)=O)=O)n2)n1,528.13,,,168310320,2468058-90-2,Inhibitor,Yes,,"SMARCA2, SMARCA4","P51531, P51532",,,FHT-5908,,C24H22N8O2S,C[C@@H](C(Nc1nc(cs1)c1cccc(c1)c1ccn(C)n1)=O)NC(c1cn(cn1)C1(CC1)C#N)=O,486.16,,,
FS-694,,C35H33FN4O4,C1Cc2cc(ccc2C(c2cc(ccc12)C(NCCN1CCOCC1)=O)=O)Nc1ccc(c(c1)NC(c1ccccc1)=O)F,592.2,10.6019/CHEMBL4507314,CHEMBL2316207,71545859,1417404-27-3,Type 1.5 binding mode inhibitor,No,Kinase domain (Type 1.5: R-Spine),MAPK14,Q16539,"PMID: 23270382 (Compound 16u), PMID: 28397331 (Compound 2), PMID: 28834431 (Compound 8b)",,FM-743,,C37H37FN4O4,CN(c1ccc2C(c3cc(ccc3CCc2c1)C(NCCN1CCOCC1)=O)=O)c1ccc(c(c1)N(C)C(c1ccccc1)=O)F,620.3,CHEMBL4586225,155567084,2772845-12-0
GNE-2256,"Compound 19, IRAK4i-2",C24H27 FN6O4,CC(C)([C@@H](CN1Cc2cc(c(cc2C1=O)N1CCOCC1)NC(c1cnn2cccnc12)=O)F)O,482.21,10.6019/CHEMBL4879554,CHEMBL4475494,129284334,2102170-43-2,Inhibitor,Yes,"hinge region, close to gatekeeper Tyr 262",IRAK4,Q9NWZ3,"PMID: 32184965 (Compound 19), PMID: 32487715 (IRAK4i-2)",WO2017108723A2 (Compound 139),GNE-6689,,C25H29FN6O4,CC(C)([C@@H](CN1Cc2cc(c(cc2C1=O)N1CCOCC1)N(C)C(c1cnn2cccnc12)=O)F)O,496.22,CHEMBL5027251,164643221,2986810-19-7
GSK046,"iBET-BD2, Compound 59",C23H27FN2O4,CC(Nc1c(cc(cc1F)C(N[C@H]1CC[C@@H](CC1)O)=O)O[C@@H](C)c1ccccc1)=O,414.2,10.6019/CHEMBL4630908,CHEMBL4636881,146018690,2474876-09-8,Inhibitor,Yes,BD2,"BRD2, BRD3, BRD4, BRDT","P25440, Q15059, O60885, Q58F21","PMID: 32691591, PMID: 34232650, PMID: 32193360",,No control,,,,,,,
GSK620,Compound 20,C18H19N3O3,CNC(C1=CC(=CN(Cc2ccccc2)C1=O)C(NC1CC1)=O)=O,325.14,10.6019/CHEMBL4630909,CHEMBL4635134,126648559,2088410-46-0,Inhibitor,Yes,BD2,"BRD2, BRD3, BRD4, BRDT","P25440, Q15059, O60885, Q58F21","PMID: 32702236, PMID: 34232650, PMID: 32193360",,No control,,,,,,,
GSK778,iBET-BD1,C30H33N5O3,Cc1c(c2cc3c(cc2OC[C@H]2CCNC2)c2c(cn3)nc(COC)n2[C@H](C)c2ccccc2)c(C)on1,511.26,10.6019/CHEMBL4630907,CHEMBL4639128,146018691,2451862-42-1,Inhibitor,Yes,BD1,"BRD2, BRD3, BRD4, BRDT","P25440, Q15059, O60885, Q58F21","PMID: 32787145 (Compound 62), PMID: 32193360",,No control,,,,,,,
GSK789,Compound 42,C26H33N5O3,CC1=Cc2c(cnc(c2NC1=O)N[C@@H]1CCN(C)C[C@H]1C(NC1CCCCC1)=O)c1ccco1,463.26,10.6019/CHEMBL4630905,CHEMBL4648362,146681130,2540591-06-6,Inhibitor,No,BD1,"BRD2, BRD3, BRD4, BRDT","P25440, Q15059, O60885, Q58F21","PMID: 32691589, PMID: 32193360",,GSK791,,C26H33N5O3,CC1=Cc2c(cnc(c2NC1=O)N[C@H]1CCN(C)C[C@@H]1C(NC1CCCCC1)=O)c1ccco1,463.26,CHEMBL4635540,156022246,
GSK973,Compound 36,C23H23FN2O4,[H][C@@]12COC[C@@]2([H])[C@@H]1NC(c1cc(C(NC)=O)c2c(c1)[C@H](c1ccccc1)[C@@H](CF)O2)=O,410.16,10.6019/CHEMBL4630902,CHEMBL4637208,132004022,2138473-38-6 ,Inhibitor,Yes,BD2,"BRD2, BRD3, BRD4, BRDT","P25440, Q15059, O60885, Q58F21","PMID: 32832027, PMID: 32193360",WO2017174620A1 (Example 26),GSK943,,C23H23FN2O4,[H][C@@]12COC[C@@]2([H])[C@@H]1NC(c1cc(C(NC)=O)c2c(c1)[C@@H](c1ccccc1)[C@H](CF)O2)=O,410.16,CHEMBL4638939,138618774,2139228-37-6
GSM1,,C25H22F4N6O2,Cc1cn(cn1)c1ccc(cc1OC)c1cn([C@H]2CCc3c(cccc3F)N(CC(F)(F)F)C2=O)nn1,514.47,10.6019/CHEMBL4507289,CHEMBL3609637,59472574,1093975-58-6,Modulator,Yes,,Gamma secretase complex (PSEN1),P49768,PMID: 26142947 (Compound 3),WO2008156580A1 (Example 11),GSM-NC,,C25H23F3N6O2,Cc1ccn(c2ccc(cc2OC)c2cn([C@H]3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)n1,496.48,CHEMBL4534005,155546818,2986643-67-6
IPP/CNRS-A017,"18d, DHODH-IN-1",C21H20F3N3O2,CC(C)Oc1c(c(C)n(c2c(cc(cn2)C2CC2)F)n1)Oc1c(cccc1F)F,403.2,10.6019/CHEMBL4507312,CHEMBL3589752,118430456,1800296-63-2,Inhibitor,No,,DHODH,Q02127,PMID: 26079043 (Compound 18d),,IPP/CNRS-A019,8m,C21H22FN3O2,CC(C)Oc1c(c(C)n(c2ccc(cn2)C2CC2)n1)Oc1ccc(cc1)F,367.2,CHEMBL3590047,118430525,1800296-30-3
JNJ-39758979,,C11H19N5,CC(C)c1cc(nc(N)n1)N1CC[C@H](C1)N,221.16,10.6019/CHEMBL5058644,CHEMBL3236549,24994634,1046447-90-8,Orthosteric antagonist,Yes,,HRH4,Q9H3N8,"PMID: 24549371, PMID: 24495018 (Compound 5)",US20080194577 (Example12 [0147]),JNJ-39668551,,C10H14F3N5,CN[C@@H]1CCN(C1)c1cc(C(F)(F)F)nc(N)n1,261.12,CHEMBL3236584,90655031,1568754-49-3
JNJ-42226314,,C26H24FN5O2S,C1CN(CCN1C1CN(C1)C(c1ccc2c(ccn2c2ccc(cc2)F)c1)=O)C(c1nccs1)=O,489.16,,CHEMBL3658400,59625954,1252765-13-1,"Non-covalent, competitive, reversible inhibitor ",Yes,Azetidine-amide carbonyl forms H-bonds with NH of Ala51 and Met123 in oxyanion hole,MGLL,Q99685,"PMID: 31818916, PMID: 32527545 (compund 6g)","US8691805B2 (Cpd 487 (probe), Cpd 1465 (control)",JNJ-8034,,C25H26N4O3,Cc1cc(C(N2CCN(CC2)C2CN(C2)C(c2ccc(cc2)c2ccccc2)=O)=O)no1,430.20,,66840364,1252771-77-9
JNJ-42396302,,C19H23N5O2,Cc1c(c2ccc(CCOC)nc2)n2c(c(ccn2)N2CCOCC2)n1,353.19,10.6019/CHEMBL4800727,CHEMBL2180408,51352628,1298030-18-8,Inhibitor,Yes,hydrophobic clamp of the catalytic site,PDE10A,Q9Y233,,WO2011051342A1 (Example B1),JNJ-40573663,,C21H25N5O,C1CN(CCC1c1ccccc1)c1cnc2c(nccn12)N1CCOCC1,363.21,CHEMBL5027912,164631600,2986221-41-2
JNJ-4355,JNJ-78394355,C40H43ClFN5O5S,Cc1c2c3c(ccc2n(CCCOc2cc(CCc4cc(CSCc5c3c(C)nn5CCOCCOC)nn4C)cc3cc(ccc23)F)c1C(O)=O)[Cl],759.27,,,156833441,2697112-32-4,Inhibitor,Yes,BCL domain,MCL1,Q07820,DOI: 10.1158/1538-7445.AM2022-2133,WO2021165370A1 (Compound 31),JNJ-78732576,,C40H42Cl2FN5O5S,Cc1c2c3c(ccc2n(CCCOc2cc(CCc4cc(CSCc5c3c(C)n(CCOCCOC)n5)nn4C)cc3c(c(ccc23)[Cl])F)c1C(O)=O)[Cl],793.23,,,2697112-60-8
JNJ-54119936,JNJB44154397,C34H33ClN4O3,CC(N1CCC(CC1)[C@](c1ccccc1)(c1ccc2c(c1)c(c(Cc1ccc(cc1)n1cccn1)c(n2)OC)[Cl])O)=O,580.22,10.6019/CHEMBL4800728,CHEMBL4802042,162677478,1599531-55-1,Inverse agonist,Yes,orthosteric site of binding domain,RORC,P51449,,"US-20140107094-A1, US-9290476-B2, EP-2909192-B1",JNJ-53721590,,C31H25Cl2N5O2,Cn1cncc1[C@](c1ccc(cc1)[Cl])(c1ccc2c(c1)c(c(Cc1ccc(cc1)n1cccn1)c(n2)OC)[Cl])O,569.14,CHEMBL4802041,162677477,1599530-54-7
JNJ-6204,JNJ-78386204,C19H11D6FN6O,[2H]C([2H])([2H])C1(Cn2c(CO1)c(c1ccnc3c1cn[nH]3)c(c1ccc(cn1)F)n2)C([2H])([2H])[2H],370.45,10.6019/CHEMBL5058645,CHEMBL5081774,162760083,2765264-50-2,Inhibitor,Yes,Kinase domain,"CSNK1D, CSNK1E","P48730, P49674",,WO2022058920A1,JNJ-0293,,C20H19FN6O,CC1(C)Cn2c(CO1)c(c1ccnc3c1cn(C)n3)c(c1ccc(cn1)F)n2,378.16,CHEMBL5087167,162760334,2765264-66-0
JNJ-65355394,,C19H26N4OS,CC(Nc1ncc(CN2CCC[C@H](Cc3cc(C)nc(C)c3)C2)s1)=O,358.18,10.6019/CHEMBL4800731,CHEMBL4802039,135135317,2230599-00-3,Agonist or Inhibitor,Yes,,OGA,O60502,,WO2018109202(A1) (Product 9),JNJ-73924149,,C19H26N4OS,CC(Nc1nc(CN2CCC[C@H](Cc3cc(C)nc(C)c3)C2)cs1)=O,358.18,CHEMBL4802044,162677479,2987636-69-9
JNJ-9350,,C25H22N6O,C(CNC(c1cc2nc(cc(c3ccccc3)n2n1)c1ccccc1)=O)Cn1ccnc1,422.19,10.6019/CHEMBL5058647,CHEMBL5094181,3113005,326923-09-5,Inhibitor,Yes,,SMOX,Q9NWM0,,,JNJ-4545,,C27H25N7O2,CC(Nc1ccc(cc1)c1cc(c2ccccc2)nc2cc(C(NCCCn3ccnc3)=O)nn12)=O,479.21,CHEMBL5092747,166632756,2962064-83-9
JP3000,,C21H13F6NO3,C1C(C1c1nc(c2ccccc2)c(c2cc(cc(c2)C(F)(F)F)C(F)(F)F)o1)C(O)=O,441.08,,,,,Agonist,No,Ligand binding domain (LBD),"RXRA, RXRB, RXRG","P19793, P28702, P48443",,,JP3001,,C21H15F6NO2,C1C(CO)C1c1nc(c2ccccc2)c(c2cc(cc(c2)C(F)(F)F)C(F)(F)F)o1,427.10,,,
KISS1-305,TP-005,C56H76N16O12,CC(C)C[C@@H](C(N[C@@H](CCCNC(=N)NC)C(N[C@@H](Cc1ccccc1)C(N)=O)=O)=O)NC(NNC([C@H](Cc1ccccc1)NC([C@H](CO)NC([C@H](CC(N)=O)NC([C@@H](Cc1ccncc1)NC([C@@H](Cc1ccc(cc1)O)N)=O)=O)=O)=O)=O)=O,1165.3,10.6019/CHEMBL4507306,CHEMBL3086284,11622248,1365623-95-5,Agonist,Yes,Kisspeptin binding site,KISS1R,Q969F8,"PMID: 24047141 (Compound 26), PMID: 24356680 (Secondary paper), PMID: 23027808 (Secondary paper)",,KISS1-543,,C49H70N16O12,CC(C)C[C@@H](C(N[C@@H](CCCNC(=N)NC)C(NCC(N)=O)=O)=O)NC(NNC([C@H](Cc1ccccc1)NC([C@H](CO)NC([C@H](CC(N)=O)NC([C@@H](Cc1cccnc1)NC([C@@H](Cc1ccc(cc1)O)N)=O)=O)=O)=O)=O)=O,1075.2,CHEMBL4588626,155567293,
MLi-2,Merck LRRK2 inhbitor-2,C21H25N5O2,[H][C@]1(C)CN(C[C@@]([H])(C)O1)c1cc(c2c3cc(ccc3[nH]n2)OC2(C)CC2)ncn1,379.2,10.6019/CHEMBL4507291,CHEMBL4098877,78319901,1627091-47-7,Inhibitor,Yes,active site (Ser935),LRRK2,Q5S007,"PMID: 28245354, PMID: 26407721 ",WO2014134774A1 (Example 51),MLi-2-NC,,C22H27N5O2,[H][C@]1(C)CN(C[C@@]([H])(C)O1)c1cc(c2c3cc(ccc3n(C)n2)OC2(C)CC2)ncn1,393.2,CHEMBL4560589,155558331,2772168-49-5
MRK-560,,C19H17ClF5NO4S2,C1CC(CCC1NS(C(F)(F)F)(=O)=O)(c1cc(ccc1F)F)S(c1ccc(cc1)[Cl])(=O)=O,517.92,10.6019/CHEMBL4507288,CHEMBL1091513,11577204,677772-84-8,Inhibitor,Yes,Protease,Gamma secretase complex (PSEN1),P49768,"PMID: 16275079 (Compound 32), PMID: 17099072 (Secondary paper), PMID: 16443723 (Secondary paper)",WO2004031139,GSI-NC,,C28H35ClF2N2O4S,CC(C)(C)OC(N1CCCC1CNC1CCC(CC1)(c1cc(ccc1F)F)S(c1ccc(cc1)[Cl])(=O)=O)=O,568.2,CHEMBL4558518,155557564,2771837-91-1
MRL-650,Naphthyridinone,C25H18Cl3N3O3,CC(C1=C(c2cc(c3ccc(cc3)[Cl])c(c3ccc(cc3[Cl])[Cl])nc2N(C)C1=O)NC(C)=O)=O,514.79,10.6019/CHEMBL4507287,CHEMBL204232,11386747,852315-00-5,Inverse agonist,Yes,,CNR1,P21554,PMID: 16263284 (Compound 14),WO2005047285A1 (Example 1),MRL-CB<sub>1</sub>-NC,MRL-CB1-NC,C24H18Cl3N3O4S,CC(C1=C(c2cc(c3ccc(cc3)[Cl])c(c3ccc(cc3[Cl])[Cl])nc2N(C)C1=O)NS(C)(=O)=O)=O,550.84,CHEMBL4578164,11364870,852315-39-0
MRL-SYKi,Syk-IN-3,C24H28N4O3S,Cc1cc(cc(c1)Nc1nccc(C)n1)c1cnc([C@]2(CC[C@H](C(O)=O)C(C)(C)C2)O)s1,452.57,10.6019/CHEMBL4507285,CHEMBL3685796,53251189,1312534-69-2,Inhibitor,Yes,Kinase domain,SYK,P43405,,WO2011075517A1 (Example 33A-68),MRL-SYKi-NC,,C25H26F3N3O3S,Cc1ccc(cc1Nc1cccc(C(F)(F)F)n1)c1cnc([C@]2(CC[C@H](C(O)=O)C(C)(C)C2)O)s1,505.16,CHEMBL4530401,155545891,2772616-92-7
MSC-4381,"MCT4i, MCT4-IN-1",C26H20ClN3O6S,CCOc1ccc(c2c1cccn2)S(Nc1ccc(cc1C#Cc1cnc(cc1OC)C(O)=O)[Cl])(=O)=O,537.08,10.6019/CHEMBL4800726,CHEMBL4802043,150189198,2445185-57-7,Inhibitor,Yes,,SLC16A3,O15427,PMID: 34382802 (Compound 18n),,MSC-0516,,C26H22N4O5S,CN(C)c1ccnc2c(cccc12)S(Nc1ccccc1C#Cc1cnc(cc1OC)C(O)=O)(=O)=O,502.13,CHEMBL4802046,151094027,2445186-08-1
MSD-CYP11B2,CYP11B2-IN-1,C18H18FN3O,CC(C)(c1cc(cnc1)c1nc2ccc(cc2n1C1CC1)F)O,311.1,10.6019/CHEMBL4507294,CHEMBL3582478,56645363,1356479-78-1,Inhibitor,Yes,,CYP11B2,P19099,PMID: 26005536 (Compound 32),WO2012012478A1 (Example 37),MSD-CYP11B2 Negative control,,C16H12F3N3,C1CC1n1c2ccc(cc2nc1c1cccnc1)C(F)(F)F,303.1,CHEMBL3582461,122179556,1706592-08-6
MSD-M1PAM,"M1PAM, PQCA",C22H20N4O3,C1CN(CCC1(C#N)c1ccccn1)CC1C=C(C(O)=O)C(N2C=CC=CC=12)=O,388.2,10.6019/CHEMBL4507295,CHEMBL1800285,25229646,1144504-35-7,Positive allosteric modulator,Yes,,CHRM1,P11229,"PMID: 21682298 (Compound 4i), PMID: 24900430 (Compound 2)",WO2009051715A1 (Example 1),MSD-M1PAM-NC,,C26H27N5O2,C1CCN(C1)C(C1=CC(CN2CCC(CC2)(C#N)c2ccccn2)=C2C=CC=CN2C1=O)=O,441.2,CHEMBL2204283,71455782,1401512-91-1
NVS-MALT1,,C24H27ClF3N5O4S,C[C@@H](c1c(cnc2cc(nn12)[Cl])Nc1ccc(cc1)[C@@H](C(F)(F)F)N(C)C(C1CCS(CC1)(=O)=O)=O)OC,573.1,10.6019/CHEMBL4507320,CHEMBL4568735,155560620,2993517-26-1,Allosteric inhibitor,Yes,interface between caspase and Ig3 domains,MALT1,Q9UDY8,,,NVS-MALT1-C,,C24H27ClF3N5O4S,C[C@@H](c1c(cnc2cc(nn12)[Cl])Nc1ccc(cc1)[C@H](C(F)(F)F)N(C)C(C1CCS(CC1)(=O)=O)=O)OC,573.1,CHEMBL4584981,155561913,
Ogerin,ZINC67740571,C17H17N5O,C(c1ccccc1)Nc1nc(c2ccccc2CO)nc(N)n1,307.14,10.6019/CHEMBL4507323,CHEMBL4548689,56707820,1309198-71-7,Positive allosteric modulator,Yes,,GPR68,Q15743,PMID: 26550826,,ZINC32547799,,C17H17N5O,C(c1ccccc1)Nc1nc(c2cccc(CO)c2)nc(N)n1,307.14,CHEMBL4460070,39791182,1125453-08-8
PF-04418948,,C23H20FNO5,COc1ccc2cc(ccc2c1)OCC1(CN(C1)C(c1ccc(cc1)F)=O)C(O)=O,409.1,10.6019/CHEMBL4507298,CHEMBL3286797,25114442,1078166-57-0,Antagonist,Yes,,PTGER2,P43116,PMID: 21595651,,PF-04475866,,C18H15BrFNO4,C1C(CN1C(c1ccc(cc1)F)=O)(COc1ccc(cc1)[Br])C(O)=O,407.0,CHEMBL4552554,59842446,1078166-46-7
PF-04457845,,C23H20F3N5O2,C1CN(CCC1=Cc1cccc(c1)Oc1ccc(cn1)C(F)(F)F)C(Nc1cccnn1)=O,455.53,10.6019/CHEMBL4507297,CHEMBL1651534,24771824,1020315-31-4,Covalent inhibitor,Yes,Active site (covalent binding to Ser241),FAAH,O00519,"PMID: 21505060, PMID: 21666860",,PF-04875474,,C21H18F3N7O2,C(/C=C/c1cncc(n1)Oc1ccc(cn1)C(F)(F)F)C1CN(C1)C(Nc1cccnn1)=O,457.1,CHEMBL4567520,155558608,2771246-83-2
PF-04554878,"Defactinib,VS-6063",C20H21F3N8O3S,CNC(c1ccc(cc1)Nc1ncc(c(NCc2c(nccn2)N(C)S(C)(=O)=O)n1)C(F)(F)F)=O,"510,49",10.6019/CHEMBL4507299,CHEMBL3137331,25117126,1073154-85-4,"Orthosteric, non-covalent reversible Type 1 inhibitor",Yes,Kinase domain,"PTK2, PTK2B","Q05397, Q14289",PMID: 24062525 (VS-6063),,PF-00911705,,C20H19F3N8O3S,CN(c1ccnc(CNc2c(cnc(Nc3ccc4c(CC(N4)=O)c3)n2)C(F)(F)F)n1)S(C)(=O)=O,508.5,CHEMBL4518706,11996298,869359-43-3
PF-05105679,,C26H21FN2O3,C[C@H](c1ccc(cc1)F)N(Cc1cccc(c1)C(O)=O)C(c1cc2ccccc2nc1)=O,428.45,10.6019/CHEMBL4507296,CHEMBL3577885,60195662,1398583-31-7,Antagonist,Yes,,TRPM8,Q7Z2W7,"PMID: 25893043, PMID: 25125580",,PF-05257137,,C26H20ClFN2O3,C[C@H](c1ccc(cc1)F)N(Cc1ccc(c(c1)C(O)=O)[Cl])C(c1cc2ccccc2nc1)=O,462.91,CHEMBL4587626,68287831,1398583-55-5
PFI-653,Vanin-1-IN-1,C18H22N6O2,C1CN(CC12CCOCC2)C(c1cnc(NCc2cnccn2)nc1)=O,354.18,10.6019/CHEMBL4800725,CHEMBL4802040,134177597,2173134-00-2,Inhibitor,Yes,near catalytic site,VNN1,O95497,,WO2018011681A1 (Compound 135),PFI-653-N,,C19H24N6O2,Cc1c(cnc(NCc2cnccn2)n1)C(N1CCC2(CCOCC2)C1)=O,368.2,CHEMBL4802047,134177666,2173133-97-4
PPTN,,C29H24F3NO2,C1CNCCC1c1ccc(cc1)c1cc(cc2cc(ccc12)c1ccc(cc1)C(F)(F)F)C(O)=O,475.2,10.6019/CHEMBL4507292,CHEMBL1800685,42611190,1160271-30-6,Antagonist,Yes,,P2RY14,Q15391,"PMID: 29767967 (Compound 1), PMID: 21689930 (Compound 2), PMID: 29253618 (Sec. paper), PMID: 23592514 (Sec. paper)",,PPTN-NC,,C30H26F3NO2,Cc1c(cc(c2ccc(cc2)C2CCNCC2)c2ccc(cc12)c1ccc(cc1)C(F)(F)F)C(O)=O,489.2,CHEMBL4566600,155561056,2772453-40-2
SAFit2,Selective Antagonist of FKBP51 by induced fit 2,C46H62N2O10,COc1ccc(CC[C@H](c2cccc(c2)OCCN2CCOCC2)OC([C@@H]2CCCCN2C([C@@H](C2CCCCC2)c2cc(c(c(c2)OC)OC)OC)=O)=O)cc1OC,802.44,10.6019/CHEMBL5058648,CHEMBL3623630,86277887,1643125-33-0,Inhibitor,Yes,FKBP-type domain 1 (Phe67),FKBP5,Q13451,"PMID: 25436518, PMID: 26954324, PMID: 33887102","WO2015039758A1 (Example 3-18, A18)",ddSAFit2,,C46H62N2O10,COc1ccc(CC[C@H](c2cccc(c2)OCCN2CCOCC2)OC([C@H]2CCCCN2C([C@H](C2CCCCC2)c2cc(c(c(c2)OC)OC)OC)=O)=O)cc1OC,802.44,CHEMBL5086970,166633549,
SGK3-PROTAC1,"PROTAC SGK3 degrader-1, DAT8, SGK3 degrader-1",C57H73FN10O11S2,Cc1ccc(c(c1)S(Nc1ccc(cc1)c1nc(c2cn[nH]c2n1)OC[C@H]1CN(CCCCCCOCCOCCOCC(N[C@H](C(N2C[C@@H](C[C@H]2C(NCc2ccc(cc2)c2c(C)ncs2)=O)O)=O)C(C)(C)C)=O)CCO1)(=O)=O)F,1156.49,,CHEMBL4795354,139035049,2381320-35-8,degrader (PROTAC),No,,SGK3,Q96BR1,PMID: 31461270 (DAT8),,cisSGK3-PROTAC1,,C57H73FN10O11S2,Cc1ccc(c(c1)S(Nc1ccc(cc1)c1nc(c2cn[nH]c2n1)OC[C@H]1CN(CCCCCCOCCOCCOCC(N[C@H](C(N2C[C@H](C[C@H]2C(NCc2ccc(cc2)c2c(C)ncs2)=O)O)=O)C(C)(C)C)=O)CCO1)(=O)=O)F,1156.49,,,
SR-302,,C32H42N6O5S,CS(N1CCCC(C1)NC([C@H](CCC1CCCCC1)NC(c1ccc(CNC(c2cnc3ccccn23)=O)cc1)=O)=O)(=O)=O,622.3,10.6019/CHEMBL4507324,CHEMBL4591082,155568238,2771319-74-3,Inhibitor,No,Kinase domain active site (DDR1),"DDR1, DDR2, MAPK11, MAPK14","Q08345, Q16832, Q15759, Q16539",PMID: 34506142,,SR-301,,C34H43N9O4S,CS(N1CCCC(C1)NC([C@H](CCC1CCCCC1)NC(c1ccc(CNc2c3c(ncn2)n(c2ccccc2)nn3)cc1)=O)=O)(=O)=O,673.3,CHEMBL4568183,155560522,2771298-56-5
SR-318,,C27H33N5O2,C1CCC(CC1)CCCNC(c1ccc(CNC(c2cnn(c3ccccc3)c2N)=O)cc1)=O,459.3,10.6019/CHEMBL4507315,CHEMBL4436748,139030333,2413286-32-3,Type 2 binding mode inhibitor,No,"Kinase domain (Type 2: adenin binding site, deep pocket)",MAPK14,Q16539,PMID: 31702918,,SR-321,,C28H31F3N4O2,C1CCC(CC1)CCCNC(c1ccc(CNC(c2cnn(c3ccccc3)c2C(F)(F)F)=O)cc1)=O,512.2,CHEMBL4531775,155546287,2410794-33-9
Skepinone-L,,C24H21F2NO4,C1Cc2cc(ccc2C(c2cc(ccc12)OC[C@@H](CO)O)=O)Nc1ccc(cc1F)F,425.1,10.6019/CHEMBL4507316,CHEMBL2152944,45279963,1221485-83-1,Type 1 binding mode inhibitor,Yes,"Kinase domain (Type 1: Gly110, Phe169, Lys53/ ATP pocket)",MAPK14,Q16539,"PMID: 22198732, PMID: 22676210 (Compound 2)",,FM-743,,C37H37FN4O4,CN(c1ccc2C(c3cc(ccc3CCc2c1)C(NCCN1CCOCC1)=O)=O)c1ccc(c(c1)N(C)C(c1ccccc1)=O)F,620.3,CHEMBL4586225,155567084,2772845-12-0
T-26c,,C24H21N3O6S  ,COc1cccc(CNC(C2NC(c3c(COCc4ccc(cc4)C(O)=O)csc3N=2)=O)=O)c1,479.51,10.6019/CHEMBL4507300,CHEMBL3337894,11525848,869296-13-9,Inhibitor,Yes,catalytic domain without coordination of catalytic Zn,MMP13,P45452,PMID: 25192810 (Compound 26c),,T-26f,,C24H24N4O3S     ,CN(Cc1ccccc1)Cc1csc2c1C(NC(C(NCc1cccc(c1)OC)=O)=N2)=O,448.54,CHEMBL3337895,59652086,869298-26-0
T3-CLK,"T3, CLK-IN-T3, CLK Inhibitor T3, VC-5561",C28H30N6O2,CC(C)(C(N1CCN(C)CC1)=O)c1ccc(cc1)C(Nc1cn2cc(ccc2n1)c1ccncc1)=O,482.2,10.6019/CHEMBL4507307,CHEMBL4531334,132585205,2109805-56-1,Inhibitor,No,ATP binding site,"CLK1, CLK2, CLK3, CLK4","P49759, P49760, P49761, Q9HAZ1","PMID: 28232751 (Compound T3), PMID: 29723265 (Sec. paper/ T3)",,T3-CLK-N,"T3N, CLK-IN-T3N",C37H47N5O2,CC(C)(C)c1cc(cc(c1)C(C)(C)C)c1ccc2nc(cn2c1)NC(c1ccc(cc1)C(C)(C)C(N1CCN(C)CC1)=O)=O,593.4,CHEMBL4576555,146673143,2561494-73-1
THPP-1,,C23H21ClN6O3,COCCOc1c2CN(CCc2nc(c2ccc(nc2)[Cl])n1)C(c1c2ccccn2cn1)=O,464.1,10.6019/CHEMBL4507293,CHEMBL2204538,49821991,1257051-63-0,Inhibitor,Yes,active site,PDE10A,Q9Y233,"PMID: 22892116, PMID: 22750078 (Sec. paper)",,THPP-1-NC,,C26H29BrN4O,CC(C)CC(N1CCc2c(C1)c(nc(c1ccc(cc1)[Br])n2)N(C)Cc1ccccc1)=O,492.2,CHEMBL4518342,155541355,2772742-52-4
TP-004,,C17H16F3N5O,Cc1c(cnc(n1)N1CC[C@H](C1)O)c1cc(cc2c1cn[nH]2)C(F)(F)F,363.1,10.6019/CHEMBL4507303,CHEMBL3799512,89794927,1454299-21-8,Inhibitor,Yes,,METAP2,P50579,PMID: 27155900 (Compound 38),WO2013130855A1 (Example 413),TPn-004,,C13H8F3N3,c1ccc(cc1)c1cc(cn2cnnc12)C(F)(F)F,263.1,CHEMBL4589954,155567827,2771561-54-5
TP-008,TGFbetaRI-IN-2,C20H15ClFN5O2,Cc1cnc(cc1N1C(N(CC(N)=O)c2cnccc12)=O)c1cc(ccc1F)[Cl],411.09,10.6019/CHEMBL4507308,CHEMBL4564126,145925651,1976038-41-1,Inhibitor,No,active site,"ACVR1B, TGFBR1","P36896, P36897","PMID: 27460209 (Compound 18), PMID: 32176847",,Al11,,C21H16ClFN4O2,Cc1cnc(cc1N1C(N(CC(N)=O)c2ccccc12)=O)c1cc(ccc1F)[Cl],410.1,CHEMBL4543737,155552436,2473561-68-9
TP-020,MGAT2-IN-1,C27H21ClF5N7O3S,Cn1c(cc(C(F)(F)F)n1)c1cnc(nc1)N1CCc2cc(cc(c12)N1CCCC1=O)S(Nc1c(cc(cc1F)[Cl])F)(=O)=O,654.01,10.6019/CHEMBL4507302,CHEMBL4455357,91885570,1800025-30-2,Inhibitor,Yes,,MGAT2,Q10469,"PMID: 26100443 (Compound 27c), PMID: 26938273 (compA)",WO2016121782A1 (Example 18),TP-020n,,C22H19ClF2N6O3S,C1CC(N(C1)c1cc(cc2CCN(c12)c1ncc(cn1)N)S(Nc1c(cc(cc1F)[Cl])F)(=O)=O)=O,520.94,CHEMBL4585920,140309892,1800025-19-7
TP-021,"BCL6 inhibitor 8c, BCL6-IN-8c",C20H20ClN3O5,C1COCCC1Oc1cc(c(cc1[N+]([O-])=O)[Cl])Nc1ccc2c(CCC(N2)=O)c1,417.84,10.6019/CHEMBL4507304,CHEMBL4075278,31801156,2130878-25-8,Inhibitor,Yes,Bric-a-brac (BTB) domain,BCL6,P41182,PMID: 28760529 (Compound 8c),,TP-021n,,C14H9ClN4O,C(c1ccc(c(c1)[Cl])Nc1ccc2c(c1)NC(N2)=O)#N,284.70,CHEMBL4063249,137635074,2131044-76-1
TP-024,FTBMT,C19H16F4N4O,Cc1cc(ccc1C(N)=O)n1c(C)nc(Cc2cc(cc(c2)F)C(F)(F)F)n1,392.35,10.6019/CHEMBL4507305,CHEMBL4082756,56649300,1358575-02-6,Agonist,Yes,,GPR52,Q9Y2T5,"PMID: 28433511 (Compound 4u), PMID: 28851764 (Sec. paper/ FTBMT)",WO2012020738A1 (Example 141),TP-024n,,C18H14F3N3OS,Cc1c(c2ccc(C(N)=O)nc2)sc(Cc2cccc(c2)C(F)(F)F)n1,377.38,CHEMBL4100408,137662140,1350930-99-2
TP-030-1,,C23H22N4O3,CN1C([C@H](COc2ccccc12)N1CCc2cn(Cc3ccccc3)nc2C1=O)=O,402.17,10.6019/CHEMBL4507327,CHEMBL4088216,135308996,2095514-75-1,Inhibitor,Yes,Type III binding mode,RIPK1,Q13546,PMID: 29485864 (Compound 14),,TP-030n,Cpd 16h,C22H26N4O5S,CN1C([C@H](COc2ccccc12)N1CCc2cn(CC3CCS(CC3)(=O)=O)nc2C1=O)=O,458.2,CHEMBL4097778,135308922,2095516-39-3
TP-030-2,,C23H21BrN4O3,CN1C([C@H](COc2ccccc12)N1CCc2c(C1=O)nn(Cc1ccccc1)c2[Br])=O,480.08,10.6019/CHEMBL4507326,CHEMBL4549667,135309104,2095514-84-2,Inhibitor,Yes,Type III binding mode,RIPK1,Q13546,PMID: 29485864 (Compound 60),,TP-030n,Cpd 16h,C22H26N4O5S,CN1C([C@H](COc2ccccc12)N1CCc2cn(CC3CCS(CC3)(=O)=O)nc2C1=O)=O,458.2,CHEMBL4097778,135308922,2095516-39-3
TP-040,,C15H22N6,CC1CCN(CC1)c1ccnc(NCc2cn(C)cn2)n1,286.19,10.6019/CHEMBL4800732,CHEMBL4778870,162640825,2757254-99-0,Inhibitor,Yes,"hydrophobic deep pocket (Tyr219, Trp278)",OGA,O60502,PMID: 33404239 (Compound 5i),,TP-040n,compound 5c,C17H23N5,CN1CCN(CC1)c1ccnc(NCCc2ccccc2)n1,297.2,CHEMBL4748908,44548528,1201173-75-2
TP-050,(R)-9,C16H15ClF2N6O,CC1=CN(C(c2cc(Cn3c(cc(C(F)F)n3)[Cl])nn12)=O)[C@H](C)CC#N,380.1,10.6019/CHEMBL5058641,CHEMBL5092058,165413047,,Positive allosteric modulator,Yes,GRIN1/GRIN2A ligand binding domain (Tyr 144),GRIN2A,Q12879,PMID: 35051811 (Compound (R)-9/ control (S)-9),,TP-050n,(S)-9,C16H15ClF2N6O,CC1=CN(C(c2cc(Cn3c(cc(C(F)F)n3)[Cl])nn12)=O)[C@@H](C)CC#N,380.1,CHEMBL5077022,166625943,
TP-051,Compound 31,C29H31FO6S,Cc1cc(cc(C)c1c1cccc(COc2ccc(CCC(O)=O)c(c2)F)c1)OC1CCS(CC1)(=O)=O,526.18,10.6019/CHEMBL5058642,CHEMBL2048623,11203294,858097-86-6,Agonist,Yes,pocket between TM1 and TM3,FFAR1,O14842,PMID: 22428944 (Compound 31),,TP-051n,,C27H27FO6S,Cc1cc(cc(C)c1c1cccc(COc2ccc(C(O)=O)c(c2)F)c1)OC1CCS(CC1)(=O)=O,498.15,CHEMBL5079207,166627367,
TP-060,"T-036, Glucosylceramide synthase-IN-1",C24H20F4N2O3,CC(C)(c1ccc(cc1)N1Cc2c(ccnc2c2ccc(cc2OCC(F)(F)F)F)C1=O)O,460.14,,CHEMBL5078078,155595464,2601393-20-6,Allosteric inhibitor (Noncompetitive against UDP-glucose),Yes,,UGCG,Q16739,"PMID: 35188773 (T-036), PMID:  34398463 (T-036), PMID:  36341811 (T-036)",,TP-060n,,C20H16N2O2,COc1cccc(c1)c1c2CN(C(c2ccn1)=O)c1ccccc1,316.12,CHEMBL5085407,166634512,2766971-12-2
UCSF924,9-6-24,C20H22N2O2,Cc1ccc2c(c1)C(C=C(CNCCCOc1ccccc1)N2)=O,322.17,10.6019/CHEMBL4507309,CHEMBL3480577,72901200,1434515-70-4,Agonist,Yes,Dopamine binding site,DRD4,P21917,PMID: 29051383 (Compound 9-6-24),,UCSF924NC,,C19H21N3O,Cc1ccc2c(c1)C(C=C(CNCCCc1ccncc1)N2)=O,307.17,CHEMBL4579981,72898300,1434696-12-4
VZ185,,C53H67FN8O8S,Cc1c(c2ccc(CNC([C@@H]3C[C@H](CN3C([C@H](C(C)(C)C)NC(C3(CC3)F)=O)=O)O)=O)c(c2)OCCCCCN2CCN(CC2)Cc2c(cc(cc2OC)C2= CN(C)C(c3cnccc23)=O)OC)scn1,994.48,,CHEMBL5182441,138454768,2306193-61-1,Degrader (PROTAC),No,,"BRD7, BRD9","Q9NPI1, Q9H8M2",PMID: 30540463 (compound 51),,cisVZ185,,C53H67FN8O8S,Cc1c(c2ccc(CNC([C@H]3C[C@H](CN3C([C@@H](C(C)(C)C)NC(C3(CC3)F)=O)=O)O)=O)c(c2)OCCCCCN2CCN(CC2)Cc2c(cc(cc2OC) C2=CN(C)C(c3cnccc23)=O)OC)scn1,994.48,,,2306193-98-4
WEB2086,"Apafant, WEB 2086BS",C22H22ClN5O2S,Cc1nnc2CN=C(c3ccccc3[Cl])c3cc(CCC(N4CCOCC4)=O)sc3n12,455.12,,CHEMBL280164,65889,105219-56-5,Inhibitor,Yes,,PTAFR,P25105,"PMID: 3598913, PMID: 3342883, PMID: 15286429",,WEB2387,(R)-bepafant,C23H22ClN5O2S,Cc1nnc2CN=C(c3ccccc3[Cl])c3c4C[C@H](Cc4sc3n12)C(N1CCOCC1)=O,467.12,,14071229,
WM-1119,WM 1119,C18H13F2N3O3S,c1ccc(c(c1)F)S(NNC(c1cc(cc(c1)F)c1ccccn1)=O)(=O)=O,389.1,10.6019/CHEMBL4507321,CHEMBL4456585,133080719,2055397-28-7,Inhibitor,Yes,AcCoA binding site,"KAT6A, KAT6B","Q92794, Q8WYB5","PMID: 30069049, PMID: 32118427",WO2016198507A1 (Example 46),WM-2474,MOZ-IN-2,C17H13FN4O3S,c1ccc(cc1)S(NNC(c1cc(ccc1F)c1ccnnc1)=O)(=O)=O,372.1,CHEMBL4446366,131750228,2055397-88-9